Brief: Enveric Biosciences Reports First Quarter 2023 Financial Results And Operational Highlights

Enveric Biosciences

15/05/2023 14:32

Enveric Biosciences Inc  ENVB.O :
    * ENVERIC BIOSCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * ENVERIC BIOSCIENCES - COST REDUCTION PLAN RESULTING IN
ABOUT 40%
TO 55% DECREASE IN EXPENSES AND EXTENSION OF FINANCIAL RUNWAY
INTO Q1 2024
    * ENVERIC BIOSCIENCES - ANNOUNCED TERMINATION OF PROPOSED
SPIN-OFF
OF CANNABINOID CLINICAL DEVELOPMENT PIPELINE TO PUBLICLY TRADED
COMPANY
    * ENVERIC BIOSCIENCES INC - NOW ENGAGING WITH STRATEGIC
ADVISORS
TO IDENTIFY AND PURSUE ALTERNATIVE VALUE-CREATING OPPORTUNITIES
FOR CANNABINOID ASSET
    * ENVERIC BIOSCIENCES INC - QTRLY LOSS PER SHARE $2.31
    * ENVERIC BIOSCIENCES INC - OPERATIONAL STREAMLINING
ENTAILED AN
ABOUT 35% REDUCTION IN FULL-TIME PERSONNEL
    * ENVERIC BIOSCIENCES - OPERATIONAL STREAMLINING ENTAILED
CANCELATION OF 7 CONSULTING CONTRACTS FOCUSED ON CANNABINOID
PROGRAMS

Source text for Eikon:  ID:nBw6FZQFba 
Further company coverage:  ENVB.O